Negative/JJ
transcriptional/JJ
regulation/NN
of/IN
human/JJ
interleukin/NN
2/CD
(/(
IL-2/NN
)/)
gene/NN
by/IN
glucocorticoids/NNS
through/IN
interference/NN
with/IN
nuclear/JJ
transcription/NN
factors/NNS
AP-1/NN
and/CC
NF-AT/NN
./.

IL-2/NN
gene/NN
transcription/NN
is/VBZ
affected/VBN
by/IN
several/JJ
nuclear/JJ
proteins/NNS
./.
=====
We/PRP
asked/VBD
whether/IN
dexamethasone/NN
(/(
Dex/NN
)/)
and/CC
cyclosporin/NN
A/NN
(/(
CsA/NN
)/)
inhibit/VBP
IL-2/NN
gene/NN
transcription/NN
by/IN
interfering/VBG
with/IN
the/DT
activity/NN
of/IN
nuclear/JJ
proteins/NNS
that/WDT
bind/VBP
to/TO
the/DT
IL-2/NN
promoter/NN
./.
=====
Nuclear/JJ
extracts/NNS
from/IN
primary/JJ
human/JJ
T/NN
lymphocytes/NNS
were/VBD
analyzed/VBN
by/IN
electrophoretic/JJ
DNA/NN
mobility/NN
shift/NN
assays/NNS
./.
=====
Both/CC
Dex/NN
and/CC
CsA/NN
inhibited/VBD
the/DT
binding/NN
of/IN
transcription/NN
factors/NNS
AP-1/NN
and/CC
NF-AT/NN
,/,
but/CC
not/RB
of/IN
NF-kB/NN
and/CC
OCT-1/OAF/NN
,/,
to/TO
their/PRP$
corresponding/JJ
sites/NNS
on/IN
the/DT
IL-2/NN
gene/NN
promoter/NN
./.
=====
To/TO
correlate/VB
changes/NNS
in/IN
nuclear/JJ
factor/NN
binding/NN
in/FW
vitro/FW
with/IN
transcriptional/JJ
activity/NN
in/FW
vivo/FW
and/CC
define/VB
the/DT
structural/JJ
requirements/NNS
for/IN
IL-2/NN
promoter/NN
repression/NN
,/,
we/PRP
used/VBD
transient/JJ
DNA/NN
transfections/NNS
./.
=====
Jurkat/NN
cells/NNS
were/VBD
transfected/VBN
with/IN
plasmids/NNS
containing/VBG
either/CC
the/DT
intact/JJ
IL-2/NN
promoter/NN
or/CC
its/PRP$
AP-1/NN
,/,
NF-AT/NN
,/,
and/CC
NF-kB/NN
motifs/NNS
./.
=====
Dex/NN
inhibited/VBD
the/DT
IL-2/NN
promoter/NN
and/CC
the/DT
AP-1/NN
,/,
but/CC
not/RB
the/DT
NF-AT/NN
and/CC
NF-kB/NN
plasmids/NNS
./.
=====
In/IN
contrast/NN
,/,
CsA/NN
inhibited/VBD
the/DT
IL-2/NN
promoter/NN
and/CC
the/DT
NF-AT/NN
,/,
but/CC
not/RB
the/DT
AP-1/NN
and/CC
NF-kB/NN
plasmids/NNS
./.
=====
These/DT
results/NNS
suggest/VBP
that/IN
in/IN
human/JJ
T/NN
lymphocytes/NNS
both/CC
Dex/NN
and/CC
CsA/NN
inhibited/VBD
IL-2/NN
gene/NN
transcription/NN
through/IN
interference/NN
with/IN
transcription/NN
factors/NNS
AP-1/NN
and/CC
NF-AT/NN
./.
=====
We/PRP
propose/VBP
that/IN
,/,
while/IN
maximum/NN
inhibition/NN
may/MD
involve/VB
interaction/NN
with/IN
both/DT
transcription/NN
factors/NNS
,/,
AP-1/NN
is/VBZ
the/DT
primary/JJ
target/NN
of/IN
Dex/NN
./.